These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10684098)

  • 1. [Clinicopathological and immunohistochemical study of hepatoblastoma].
    Zhang X; Li F; Cheng N
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep; 29(3):298-301. PubMed ID: 10684098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
    Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
    Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SALL4 is a marker of the embryonal subtype of hepatoblastoma.
    Gnemmi V; Leteurtre E; Sudour-Bonnange H; Devisme L; Guettier C; Buob D; Leroy X
    Histopathology; 2013 Sep; 63(3):425-8. PubMed ID: 23822878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
    Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
    Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glypican 3 expression in hepatoblastoma and its diagnostic implication].
    Wang FH; Wen JM; Vong HT; Yip YC
    Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):806-9. PubMed ID: 24507097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of PAS and β-catenin staining in histological categorisation and prediction of prognosis of hepatoblastomas.
    Bera G; Das RN; Roy P; Ghosh R; Islam N; Mishra PK; Chatterjee U
    Pediatr Surg Int; 2017 Sep; 33(9):961-970. PubMed ID: 28631020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable antigen expression in hepatoblastomas.
    Ramsay AD; Bates AW; Williams S; Sebire NJ
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):140-7. PubMed ID: 18227729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Catenin and met deregulation in childhood Hepatoblastomas.
    Ranganathan S; Tan X; Monga SP
    Pediatr Dev Pathol; 2005; 8(4):435-47. PubMed ID: 16211454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FNAC Aided Diagnosis and Categorization of Hepatoblastoma:: A Report of Three Cases.
    Bera G; Das RN; Islam N; Roy P; Mishra PK; Datta C; Chaudhuri MK; Chatterjee U
    Diagn Cytopathol; 2017 Jan; 45(1):77-82. PubMed ID: 27629393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression predicts metachronous pulmonary metastasis and poor survival in patients with hepatoblastoma.
    Tsukada M; Wakai T; Matsuda Y; Korita PV; Shirai Y; Ajioka Y; Hatakeyama K; Kubota M
    J Pediatr Surg; 2009 Aug; 44(8):1522-8. PubMed ID: 19635299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine needle aspiration cytology of hepatoblastoma. Recognition of subtypes on cytomorphology.
    Iyer VK; Kapila K; Agarwala S; Verma K
    Acta Cytol; 2005; 49(4):355-64. PubMed ID: 16124162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ; Richardson MS; Austin RM; Kurman RJ
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases.
    Zynger DL; Gupta A; Luan C; Chou PM; Yang GY; Yang XJ
    Hum Pathol; 2008 Feb; 39(2):224-30. PubMed ID: 17949790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cells in hepatoblastoma lack "oval" cell phenotype.
    Badve S; Logdberg L; Lal A; de Davila MT; Greco MA; Mitsudo S; Saxena R
    Mod Pathol; 2003 Sep; 16(9):930-6. PubMed ID: 13679457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 protein expression in hepatoblastoma: an immunohistochemical investigation.
    Ruck P; Xiao JC; Kaiserling E
    Pediatr Pathol; 1994; 14(1):79-85. PubMed ID: 8159623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations.
    Heifetz SA; French M; Correa M; Grosfeld JL
    Pediatr Pathol Lab Med; 1997; 17(6):857-74. PubMed ID: 9353826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of CD44 expression in children with hepatoblastoma.
    Cai HY; Yu B; Feng ZC; Qi X; Wei XJ
    Genet Mol Res; 2015 Oct; 14(4):13203-7. PubMed ID: 26535633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High tricellulin expression is associated with better survival in human hepatoblastoma.
    Schlachter K; Gyugos M; Halász J; Lendvai G; Baghy K; Garami M; Gyöngyösi B; Schaff Z; Kiss A
    Histopathology; 2014 Nov; 65(5):631-41. PubMed ID: 24735023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine differentiation in hepatoblastoma. An immunohistochemical investigation.
    Ruck P; Harms D; Kaiserling E
    Am J Surg Pathol; 1990 Sep; 14(9):847-55. PubMed ID: 2167615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.